These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 17557033

  • 1. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L, Naves LA, Freitas MC, Lima M, Canadas V, Albuquerque JL, Lyra R, Azevedo MF, Casulari LA.
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [Abstract] [Full Text] [Related]

  • 2. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC, Hsieh CJ.
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [Abstract] [Full Text] [Related]

  • 3. Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance.
    Elenkova A, Genov N, Abadzhieva Z, Kirilov G, Vasilev V, Kalinov K, Zacharieva S.
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):201-5. PubMed ID: 23595795
    [Abstract] [Full Text] [Related]

  • 4. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E, Löcsei Z, Szabolcs I, Kneffel P, Góth M, Szöke D, Kovács LG.
    Orv Hetil; 2003 Oct 26; 144(43):2121-7. PubMed ID: 14661444
    [Abstract] [Full Text] [Related]

  • 5. Clinical characterization of patients with macroprolactinemia and monomeric hyperprolactinemia.
    Can M, Guven B, Atmaca H, Acıkgoz S, Mungan G.
    Kaohsiung J Med Sci; 2011 May 26; 27(5):173-6. PubMed ID: 21527183
    [Abstract] [Full Text] [Related]

  • 6. Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.
    Tütüncüler F, Darendeliler F, Aygün M, Hekim N.
    Turk J Pediatr; 2006 May 26; 48(2):143-7. PubMed ID: 16848115
    [Abstract] [Full Text] [Related]

  • 7. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
    Radavelli-Bagatini S, Lhullier FL, Mallmann ES, Spritzer PM.
    Neuro Endocrinol Lett; 2013 May 26; 34(3):207-11. PubMed ID: 23685418
    [Abstract] [Full Text] [Related]

  • 8. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
    Kasum M, Orešković S, Čehić E, Šunj M, Lila A, Ejubović E.
    Taiwan J Obstet Gynecol; 2017 Dec 26; 56(6):719-724. PubMed ID: 29241908
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic evaluation of hyperprolactinemia.
    Biller BM.
    J Reprod Med; 1999 Dec 26; 44(12 Suppl):1095-9. PubMed ID: 10649817
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of pituitary adenomas in macroprolactinemic patients may be higher than it is presumed.
    Tamer G, Telci A, Mert M, Uzum AK, Aral F, Tanakol R, Yarman S, Boztepe H, Colak N, Alagöl F.
    Endocrine; 2012 Feb 26; 41(1):138-43. PubMed ID: 21959531
    [Abstract] [Full Text] [Related]

  • 11. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M, Pavičić-Baldani D, Stanić P, Orešković S, Sarić JM, Blajić J, Juras J.
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec 26; 183():28-32. PubMed ID: 25461348
    [Abstract] [Full Text] [Related]

  • 12. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
    Espinós JJ, Vanrell C, Gich I, Urgell E, Calaf J.
    Gynecol Endocrinol; 2017 Feb 26; 33(2):148-151. PubMed ID: 27841032
    [Abstract] [Full Text] [Related]

  • 13. Frequency of Macroprolactin in Hyperprolactinemia.
    Sherazi NA, Baig MZ, Khan AH.
    J Coll Physicians Surg Pak; 2018 Feb 26; 28(2):93-97. PubMed ID: 29394965
    [Abstract] [Full Text] [Related]

  • 14. [Usefulness of determining serum levels of prolactin in women with menstruation disorders].
    Starzewski J, Niespodziański K, Kowalski D, Kowalska K, Piasek G, Chlewicka B.
    Przegl Lek; 1989 Feb 26; 46(10):728-31. PubMed ID: 2594991
    [Abstract] [Full Text] [Related]

  • 15. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E, Schivardi MR, Falsetti L, Gastaldi A.
    Minerva Ginecol; 1989 Mar 26; 41(3):157-60. PubMed ID: 2666885
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and reproductive manifestations of macroprolactinemia.
    Kalsi AK, Halder A, Jain M, Chaturvedi PK, Sharma JB.
    Endocrine; 2019 Feb 26; 63(2):332-340. PubMed ID: 30269265
    [Abstract] [Full Text] [Related]

  • 17. [Hyperprolactinemia unrelated to prolactinoma].
    Krysiak R, Okopień B.
    Wiad Lek; 2014 Feb 26; 67(2 Pt 1):101-11. PubMed ID: 25764785
    [Abstract] [Full Text] [Related]

  • 18. Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma.
    Cavaco B, Leite V, Santos MA, Arranhado E, Sobrinho LG.
    J Clin Endocrinol Metab; 1995 Aug 26; 80(8):2342-6. PubMed ID: 7629227
    [Abstract] [Full Text] [Related]

  • 19. The importance of macroprolactinemia in the differential diagnosis of hyperprolactinemic patients.
    Bağdatoğlu C, Bağdatoğlu OT, Muslu N, Köseoğlu A, Dağtekin A, Polat G, Dolgun H, Karataş MA.
    Turk Neurosurg; 2008 Jul 26; 18(3):223-7. PubMed ID: 18814107
    [Abstract] [Full Text] [Related]

  • 20. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
    Suliman AM, Smith TP, Gibney J, McKenna TJ.
    Clin Chem; 2003 Sep 26; 49(9):1504-9. PubMed ID: 12928232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.